TP53 and liver dysplastic nodule: The expression of miR-770-5p in podocytes is upregulated under high-glucose conditions, and the downregulation of miR-770-5p by targeting TRIAP1 can eliminate podocytes induced by high glucose and inhibit cell apoptosis, which further proves that TP53 has a potential role in the occurrence and development of DN [22].